|
WO2016187356A1
(en)
*
|
2015-05-18 |
2016-11-24 |
Agensys, Inc. |
Antibodies that bind to axl proteins
|
|
WO2016187354A1
(en)
*
|
2015-05-18 |
2016-11-24 |
Agensys, Inc. |
Antibodies that bind to axl proteins
|
|
US20180128545A1
(en)
|
2016-11-08 |
2018-05-10 |
Berry Metal Company |
Modular furnace cooling wall
|
|
US12384811B2
(en)
|
2019-04-05 |
2025-08-12 |
Academia Sinica |
Sialidase-resistant saccharide and method of making and using the same
|
|
TWI789711B
(zh)
*
|
2020-02-24 |
2023-01-11 |
中國科學院微生物研究所 |
新型冠狀病毒的人源單克隆抗體及其應用
|
|
FI4045533T3
(fi)
|
2020-03-26 |
2024-02-02 |
Univ Vanderbilt |
Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2)
|
|
CR20220552A
(es)
|
2020-04-02 |
2023-01-17 |
Regeneron Pharma |
Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno
|
|
KR20230038416A
(ko)
|
2020-05-08 |
2023-03-20 |
아카데미아 시니카 |
키메릭 인플루엔자 백신
|
|
WO2021231976A1
(en)
|
2020-05-14 |
2021-11-18 |
Xencor, Inc. |
Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
|
|
AU2021275361A1
(en)
*
|
2020-05-17 |
2023-01-19 |
Astrazeneca Uk Limited |
SARS-CoV-2 antibodies and methods of selecting and using the same
|
|
CA3181026A1
(en)
|
2020-06-03 |
2021-12-09 |
Samit GANGULY |
Methods for treating or preventing sars-cov-2 infections and covid-19 with anti-sars-cov-2 spike glycoprotein antibodies
|
|
US20220003779A1
(en)
*
|
2020-07-03 |
2022-01-06 |
The Research Foundation For The State University Of New York |
Methods for qualitative and quantitative analysis of a plurality of biomarkers
|
|
EP4182687A4
(en)
*
|
2020-07-20 |
2024-09-11 |
Bio-Rad Laboratories, Inc. |
IMMUNOASSAY FOR SARS-COV-2 NEUTRALISING ANTIBODIES AND MATERIALS THEREFOR
|
|
WO2022035918A1
(en)
*
|
2020-08-11 |
2022-02-17 |
Eli Lilly And Company |
Anti-sars-cov-2 antibodies
|
|
AR123688A1
(es)
*
|
2020-10-02 |
2023-01-04 |
Lilly Co Eli |
Métodos para reducir el contenido de proteínas de célula huésped en procesos de purificación de proteínas
|
|
US11440952B2
(en)
|
2020-10-16 |
2022-09-13 |
Invisishield Technologies Ltd. |
Compositions for preventing or treating viral and other microbial infections
|
|
WO2022162587A1
(en)
*
|
2021-01-27 |
2022-08-04 |
Centre Hospitalier Universitaire Vaudois (C.H.U.V.) |
Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection
|
|
CN115141270A
(zh)
*
|
2021-03-29 |
2022-10-04 |
深圳市康麦生物技术有限公司 |
特异性结合新型冠状病毒的抗体
|
|
AU2022257113B2
(en)
|
2021-04-12 |
2024-07-18 |
Academia Sinica |
Improved coronavirus vaccine
|
|
CN113461810B
(zh)
*
|
2021-05-17 |
2021-12-28 |
深圳市福田区格物智康病原研究所 |
一种抗新型冠状病毒刺突蛋白的全人源单克隆抗体及其应用
|
|
CA3221441A1
(en)
*
|
2021-06-08 |
2022-12-15 |
Yu Tang |
2019 novel coronavirus antibody-containing pharmaceutical formulations
|
|
WO2022263638A1
(en)
*
|
2021-06-17 |
2022-12-22 |
Centre Hospitalier Universitaire Vaudois (C.H.U.V.) |
Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection
|
|
WO2023285620A2
(en)
*
|
2021-07-14 |
2023-01-19 |
Alchemab Therapeutics Ltd. |
Compositions and methods for targeting viral proteins
|
|
IL310012A
(en)
|
2021-07-14 |
2024-03-01 |
Regeneron Pharma |
Antibodies against SARS-COV-2 spike glycoprotein and antigen-binding fragments
|
|
US12600764B2
(en)
*
|
2021-08-27 |
2026-04-14 |
International Business Machines Corporation |
Antigen-binding proteins targeting coronavirus (COV) variants
|
|
CN113735969B
(zh)
*
|
2021-09-20 |
2023-05-12 |
中国人民解放军军事科学院军事医学研究院 |
一种全人源抗新冠病毒广谱高中和活性单克隆抗体及应用
|
|
TW202334429A
(zh)
*
|
2021-10-01 |
2023-09-01 |
中央研究院 |
Sars-cov-2棘蛋白特異性抗體及其用途
|
|
US20240400653A1
(en)
*
|
2021-10-07 |
2024-12-05 |
Seqirus Pty Ltd |
Anti-sars-cov-2 antibodies and uses thereof i
|
|
WO2023059900A2
(en)
*
|
2021-10-08 |
2023-04-13 |
Invivyd, Inc. |
Pharmaceutical formulations comprising anti-coronavirus s protein antibodies and uses thereof
|
|
WO2023070051A1
(en)
*
|
2021-10-22 |
2023-04-27 |
Atreca, Inc. |
Antibodies to coronavirus sars-cov-2
|
|
WO2023076419A2
(en)
*
|
2021-10-27 |
2023-05-04 |
Twist Bioscience Corporation |
Sars-cov-2 antibodies and methods of use
|
|
WO2023079137A1
(en)
*
|
2021-11-05 |
2023-05-11 |
Katholieke Universiteit Leuven |
Neutralizing anti-sars-cov-2 human antibodies
|
|
US20250034234A1
(en)
*
|
2021-11-09 |
2025-01-30 |
Rhode Island Hospital |
Predicting covid-19 antibodies among survivors with deep rna sequencing
|
|
EP4430070A1
(en)
*
|
2021-11-12 |
2024-09-18 |
RQ Biotechnology Limited |
Compositions
|
|
MX2024005999A
(es)
*
|
2021-11-19 |
2024-05-30 |
Ap Biosciences Inc |
Anticuerpos bispecificos dirigidos a cd137 y usos de los mismos para la inmunoterapia anticancer.
|
|
EP4183800A1
(en)
*
|
2021-11-19 |
2023-05-24 |
Medizinische Hochschule Hannover |
Novel sars-cov-2 neutralizing antibodies
|
|
CN116217711A
(zh)
*
|
2021-12-03 |
2023-06-06 |
广东菲鹏生物有限公司 |
一种SARS-CoV-2检测方法和试剂盒
|
|
KR102793620B1
(ko)
|
2021-12-09 |
2025-04-09 |
한국화학연구원 |
사스-코로나바이러스-2 뉴클레오캡시드 단백질에 대한 단클론 항체 및 이의 용도
|
|
WO2023133338A2
(en)
*
|
2022-01-10 |
2023-07-13 |
University Of Pittsburgh – Of The Commonwealth System Of Higher Education |
Molecules that bind to neutrophil elastase polypeptides
|
|
CN119421953A
(zh)
|
2022-01-28 |
2025-02-11 |
株式会社伊贝克 |
具有突变株交叉性的抗SARS－CoV－2人中和抗体及其抗原结合片段
|
|
WO2023159061A2
(en)
*
|
2022-02-15 |
2023-08-24 |
Board Of Regents, The University Of Texas System |
Human monoclonal antibodies targeting the s2 subunit of the sars-cov-2 spike protein
|
|
TW202342510A
(zh)
|
2022-02-18 |
2023-11-01 |
英商Ｒｑ生物科技有限公司 |
抗體
|
|
CN119110809A
(zh)
|
2022-02-23 |
2024-12-10 |
Xencor股份有限公司 |
抗CD28 x抗PSMA抗体
|
|
WO2023159316A1
(en)
*
|
2022-02-28 |
2023-08-31 |
Immune Biosolutions Inc. |
Formulation of anti-sars-cov-2 neutralizing antibodies and uses thereof
|
|
WO2023168195A2
(en)
*
|
2022-03-04 |
2023-09-07 |
The Scripps Research Institute |
Human broadly neutralizing antibodies against betacoronaviruses
|
|
WO2023178182A1
(en)
*
|
2022-03-16 |
2023-09-21 |
10X Genomics, Inc. |
Compositions and methods for detection and treatment of coronavirus infection
|
|
CN114349855B
(zh)
*
|
2022-03-18 |
2022-06-28 |
百斯医学诊断科技(北京)有限公司 |
新型冠状病毒Delta突变株特异性抗体及其应用
|
|
WO2023183848A2
(en)
*
|
2022-03-25 |
2023-09-28 |
The Rockefeller University |
Anti-sars-cov-2 antibodies and methods of use thereof
|
|
EP4505179A2
(en)
*
|
2022-04-01 |
2025-02-12 |
Invivyd, Inc. |
Sars-cov2 antibodies and uses thereof
|
|
CN114656555B
(zh)
*
|
2022-04-08 |
2024-03-19 |
广州医科大学附属第一医院（广州呼吸中心） |
抗SARS-CoV-2病毒的中和抗体及其制备方法和应用
|
|
WO2023201306A1
(en)
|
2022-04-14 |
2023-10-19 |
Invisishield Technologies Ltd. |
Compositions for preventing or treating influenza infections
|
|
CA3256035A1
(en)
|
2022-04-14 |
2023-10-19 |
Invisishield Technologies Ltd. |
COMPOSITIONS FOR PREVENTING OR TREATMENT OF CORONAVIRUS INFECTIONS
|
|
TW202409073A
(zh)
*
|
2022-07-26 |
2024-03-01 |
圓祥生技股份有限公司 |
SARS-CoV-2抗體及雙特異性抗體
|
|
CN116143910B
(zh)
*
|
2022-10-12 |
2026-03-24 |
水木未来(北京)科技有限公司 |
靶向SARS-CoV-2刺突蛋白的纳米抗体及其应用
|
|
KR20250122456A
(ko)
*
|
2022-11-01 |
2025-08-13 |
프로비던스 헬스 앤드 서비시즈 - 오레곤 |
Fas 리간드에 특이적인 단일클론 항체 및 이의 용도
|
|
EP4638490A1
(en)
|
2022-12-21 |
2025-10-29 |
National University of Singapore |
Sars-cov-2 spike protein-binding molecules
|
|
WO2024187177A2
(en)
*
|
2023-03-09 |
2024-09-12 |
The Johns Hopkins University |
Recombinant antibody for the treatment of extracellular dna overload
|
|
CN121240887A
(zh)
|
2023-04-08 |
2025-12-30 |
磐石医药生技股份有限公司 |
通过聚合物囊泡进行靶向递送的方法和组合物
|
|
US12508235B2
(en)
|
2023-04-08 |
2025-12-30 |
Rock Biomedical, Inc. |
Methods and compositions for dendritic cell targeting nano-delivery
|
|
WO2024238734A2
(en)
|
2023-05-17 |
2024-11-21 |
Rock Biomedical Inc. |
Mgat1 deficient cells and uses thereof
|
|
WO2025222126A1
(en)
*
|
2024-04-19 |
2025-10-23 |
Vanderbilt University |
Var2csa antibodies and methods of use thereof
|
|
US20260061066A1
(en)
*
|
2024-06-03 |
2026-03-05 |
Uct Bioscience Co., Ltd. |
Anti-grp78 antibody, immunoconjugate and uses thereof
|